Mr Mrs Miss Ms Dr Other

Dr
Achim
Krebs

Partner & Patent Attorney

The Hague Office

Chemistry

Telephone. +31(0) 702 400 899
Mobile. +31(0) 615 364 665
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.

Experience

Achim's practice covers a wide range of chemical, pharmaceutical and high tech inventions, and he is acting for a diverse range of companies across these technologies, from start-ups to multinationals.

Achim regularly advises clients on the IP aspects of complex technologies, and on the creation and management of cost-effective IP portfolios.

He also regularly represents clients in Opposition and Appeal Proceedings before the European Patent Office, and often supports clients in multi-jurisdictional contentious situations.

Another field involves due diligence investigations into IP portfolios of technology companies, primarily for venture capital and private equity investors.

Achim is presently serving as President of the LES Benelux.

Achim is qualified as a Dutch, Belgian and European Patent Attorney, and he is a registered European Trade Mark and Design Attorney.

Qualifications

Patent Attorney

Dutch
Europe
Belgian

Trade Mark Attorney

Europe


PHD

Dr. Rer. Nat.

POSTGRADUATE DIPLOMA OR CERTIFICATE

CEIPI Patent Litigation

POSTGRADUATE DIPLOMA OR CERTIFICATE

Polymer RSC

OTHER

Dipl. Chem.

Recognition

IAM Patent 1000

"Achim Krebs appreciates what clients really need and gives made-to-measure advice. He is strategic and has a strong commercial understanding of intellectual property and how it can be used to serve business purposes.” He protects chemical, pharmaceutical and mechanical inventions from his base at HGF in The Hague.

View recognition online

Publications

IAM Global Patent Prosecution 2023

View publication online

IAM Patent 1000 2022

View publication online

IAM Patent 1000 2020

View publication online

IAM Patent 1000 2019

View publication online

Chair WIPO ADR Seminar

View publication online

LES China and CNIPA Licensing Courses 2017 to 2019

Conferences: 2022

October 25th 2022

Webinar: Litigating in the Unified Patent Court

Speaker

Event details

March 7th 2022

IQPC Global Exchange Europe 2022

Attended

Event details

Conferences: 2020

October 12th 2020

LES Benelux Licensing Course 2018

Speaker

Event details

Conferences: 2019

November 4th 2019

LES Benelux Licensing course 2019 - The Hague

Speaker

Event details

Conferences: 2016

April 21st 2016

Topic Meeting IP & Tax – Quo Vadis!

Speaker

Conferences: 2013

September 6th 2013

Conference on Green Technologies - IP, Technology Transfer and Dispute Resolution in the Energy Sector

Speaker

Event details

Conferences: 2012

March 22nd 2012

Thomson Reuters IP Seminar

Speaker

Event details

CSR

President of the Licensing Executive Society for the Benelux for 2020/2021. Secretary LES Benelux 2008-2018.

Related News

Event - 4th March 2024

INTA 2024 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 18th-22nd May 2024 in Atlanta, Georgia. The conference will connect some of the …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 2: Sippin’ Success with Trade Marks

In the UK, trade marks and the food and drink industry have a long and rich heritage.  One of the most well known of these stories begins in 1876, when …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.